Tabimorelin

DB20892ExperimentalSmall molecule

Tabimorelin is a small molecule drug. The usage of the INN stem '-relin' in the name indicates that Tabimorelin is a pituitary hormone-release stimulating peptide. Tabimorelin has a monoisotopic molecular...

Mechanism: Pharmacologically active on Cytochrome P450 3A4 and Growth hormone secretagogue receptor type 1
Curator reviewed
Formula / weight: C₃₂H₄₀N₄O₃ · 528.697 g/mol (avg)
Code names: NN-703 · NNC-26-0703

Resolves to

Compound

UNIIL51CBE03KFCAS193079-69-5ChEMBLCHEMBL281764ChEBI748054PubChem9810101

Structure

InChIKeyWURGZWOTGMLDJP-ZCYANPAGSA-NSMILESCNC(=O)[C@@H](CC1=CC=CC=C1)N(C)C(=O)[C@@H](CC1=CC2=CC=CC=C2C=C1)N(C)C(=O)\C=C\CC(C)(C)N

Targets

P08684CYP3A4Q92847GHSR

What you can answer from here — as of September 23, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

8+ReferencesStructured and connected to the statements they support

Which drugs share a target with Tabimorelin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account